Bridgewater Associates LP Has $3.01 Million Stake in Genpact Limited (NYSE:G)

Bridgewater Associates LP cut its stake in Genpact Limited (NYSE:G - Free Report) by 49.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 76,821 shares of the business services provider's stock after selling 74,798 shares during the quarter. Bridgewater Associates LP's holdings in Genpact were worth $3,012,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets lifted its stake in Genpact by 78.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 47,957 shares of the business services provider's stock worth $1,880,000 after acquiring an additional 21,140 shares in the last quarter. Centaurus Financial Inc. acquired a new stake in Genpact in the 3rd quarter worth about $159,000. Cerity Partners LLC increased its position in Genpact by 136.4% during the 3rd quarter. Cerity Partners LLC now owns 17,935 shares of the business services provider's stock worth $703,000 after purchasing an additional 10,349 shares in the last quarter. Landscape Capital Management L.L.C. acquired a new stake in Genpact during the 3rd quarter valued at $540,000. Finally, Advisors Asset Management Inc. boosted its holdings in Genpact by 3.4% in the third quarter. Advisors Asset Management Inc. now owns 6,885 shares of the business services provider's stock worth $270,000 after purchasing an additional 226 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the company's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares in the company, valued at approximately $12,407,545.60. This represents a 3.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.80% of the company's stock.

Genpact Stock Performance

Genpact stock traded down $0.33 during midday trading on Friday, hitting $46.16. 752,258 shares of the company's stock were exchanged, compared to its average volume of 1,596,334. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $47.98. The stock has a market cap of $8.14 billion, a price-to-earnings ratio of 12.68, a price-to-earnings-growth ratio of 1.59 and a beta of 1.13. The firm's 50 day simple moving average is $41.17 and its 200 day simple moving average is $37.00.

Genpact Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be given a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Monday, December 9th. Genpact's dividend payout ratio (DPR) is 16.76%.

Analyst Ratings Changes

G has been the topic of a number of research analyst reports. JPMorgan Chase & Co. boosted their price objective on shares of Genpact from $35.00 to $43.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. Needham & Company LLC lifted their price objective on shares of Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a research note on Monday, November 11th. Jefferies Financial Group lifted their price target on Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research note on Monday, September 9th. Robert W. Baird increased their price target on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research note on Friday, November 8th. Finally, BMO Capital Markets raised their price target on shares of Genpact from $38.00 to $42.00 and gave the stock a "market perform" rating in a research report on Monday, August 12th. Eight research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $42.33.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.